121 related articles for article (PubMed ID: 31587352)
1. Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience.
Tremblay D; Vogel AS; Moshier E; Hoffman R; Kremyanskaya M; Zhou S; Schiano T; Mascarenhas J
Eur J Haematol; 2020 Jan; 104(1):72-73. PubMed ID: 31587352
[No Abstract] [Full Text] [Related]
2. Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases.
Lavu S; Szuber N; Mudireddy M; Yogarajah M; Gangat N; Pardanani A; Hanson CA; Ketterling RP; Ashrani AA; Kamath PS; Tefferi A
Am J Hematol; 2018 Mar; 93(3):E61-E64. PubMed ID: 29194707
[No Abstract] [Full Text] [Related]
3. Survival in patients with familial and sporadic myeloproliferative neoplasms.
Hultcrantz M; Lund SH; Landgren O; Samuelsson J; Goldin LR; Oddsson A; Björkholm M; Kristinsson SY
Blood; 2015 Jun; 125(23):3665-6. PubMed ID: 26045595
[No Abstract] [Full Text] [Related]
4. Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patients.
Gangat N; Morsia E; Foran JM; Palmer JM; Elliott MA; Tefferi A
Br J Haematol; 2020 Dec; 191(5):e120-e124. PubMed ID: 32945528
[No Abstract] [Full Text] [Related]
5. Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report.
Waiswa M; Seremba E; Ocama P; Ddungu H; Opio K; Okello C; O'shea T; Verhovsek M; Mutyabule R
Afr Health Sci; 2014 Dec; 14(4):1069-73. PubMed ID: 25834519
[TBL] [Abstract][Full Text] [Related]
6. Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis.
How J; Trinkaus KM; Oh ST
Br J Haematol; 2018 Oct; 183(2):310-313. PubMed ID: 29048104
[No Abstract] [Full Text] [Related]
7. Heterogeneity among splanchnic vein thrombosis associated with myeloproliferative neoplasms.
Cattaneo D; Gianelli U; Bianchi P; Cortelezzi A; Iurlo A
Eur J Intern Med; 2018 Jun; 52():e25-e26. PubMed ID: 29567096
[No Abstract] [Full Text] [Related]
8. Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms.
Akpan IJ; Stein BL
Curr Hematol Malig Rep; 2018 Jun; 13(3):183-190. PubMed ID: 29644531
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.
Deschamps P; Moonim M; Radia D; Curto-Garcia N; Woodley C; Bassiony S; O'Sullivan J; Harrington P; Raj K; Francis Y; Kordasti S; Ali S; Harrison CN; McLornan DP
Br J Haematol; 2021 May; 193(4):792-797. PubMed ID: 33751548
[TBL] [Abstract][Full Text] [Related]
10. Splanchnic vein thrombosis in acute pancreatitis: a single-center experience.
Harris S; Nadkarni NA; Naina HV; Vege SS
Pancreas; 2013 Nov; 42(8):1251-4. PubMed ID: 24152951
[TBL] [Abstract][Full Text] [Related]
11. The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis.
Goodyer M; Langabeer SE; Haslam K; Murphy K
Pathol Oncol Res; 2016 Jan; 22(1):229-30. PubMed ID: 26450123
[No Abstract] [Full Text] [Related]
12. [Any splanchnic vein thrombosis must make look for a forme fruste of myeloproliferative disorder].
Casadevall N; Valla D
Rev Prat; 2005 Oct; 55(15):1669-70. PubMed ID: 16334203
[No Abstract] [Full Text] [Related]
13. Absence of JAK2V617F mutation in Chinese deep vein thrombosis patients without myeloproliferative neoplasms.
Dong B; Zhang Y; Fu X; Wang G
Thromb Res; 2012 May; 129(5):664-5. PubMed ID: 22197451
[No Abstract] [Full Text] [Related]
14. Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
Galtier J; Drevon L; Le Bris Y; Giraudier S; Wemeau M; Legros L; Paz DL; Girodon F; Kiladjian JJ; Mesguich C; Parrens M; Mediavilla C; Roy L; Guy A; Mansier O; Ianotto JC; James C
Haematologica; 2024 Jun; 109(6):1989-1993. PubMed ID: 38328854
[No Abstract] [Full Text] [Related]
15. Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.
Gianelli U; Iurlo A; Cattaneo D; Bossi A; Cortinovis I; Augello C; Moro A; Savi F; Castelli R; Brambilla C; Bianchi P; Primignani M; Cortelezzi A; Bosari S
Leuk Res; 2015 May; 39(5):525-9. PubMed ID: 25840747
[TBL] [Abstract][Full Text] [Related]
16. The role of thrombophilia in splanchnic vein thrombosis.
Primignani M; Mannucci PM
Semin Liver Dis; 2008 Aug; 28(3):293-301. PubMed ID: 18814082
[TBL] [Abstract][Full Text] [Related]
17. Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study.
Martinelli I; De Stefano V; Carobbio A; Randi ML; Santarossa C; Rambaldi A; Finazzi MC; Cervantes F; Arellano-Rodrigo E; Rupoli S; Canafoglia L; Tieghi A; Facchini L; Betti S; Vannucchi AM; Pieri L; Cacciola R; Cacciola E; Cortelezzi A; Iurlo A; Pogliani EM; Elli EM; Spadea A; Barbui T
Am J Hematol; 2014 Nov; 89(11):E200-5. PubMed ID: 25042466
[TBL] [Abstract][Full Text] [Related]
18. Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
Sant'Antonio E; Guglielmelli P; Pieri L; Primignani M; Randi ML; Santarossa C; Rumi E; Cervantes F; Delaini F; Carobbio A; Betti S; Rossi E; Lavi N; Harrison CN; Curto-Garcia N; Gisslinger H; Gisslinger B; Specchia G; Ricco A; Vianelli N; Polverelli N; Koren-Michowitz M; Ruggeri M; Girodon F; Ellis M; Iurlo A; Mannelli F; Mannelli L; Sordi B; Loscocco GG; Cazzola M; De Stefano V; Barbui T; Tefferi A; Vannucchi AM
Am J Hematol; 2020 Feb; 95(2):156-166. PubMed ID: 31721282
[TBL] [Abstract][Full Text] [Related]
19. Splanchnic vein thrombosis in myeloproliferative neoplasms.
Sekhar M; McVinnie K; Burroughs AK
Br J Haematol; 2013 Sep; 162(6):730-47. PubMed ID: 23855810
[TBL] [Abstract][Full Text] [Related]
20. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
Amitrano L; Guardascione MA; Ames PR; Margaglione M; Antinolfi I; Iannaccone L; Annunziata M; Ferrara F; Brancaccio V; Balzano A
Am J Hematol; 2003 Feb; 72(2):75-81. PubMed ID: 12555209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]